Private MarketsSmartkarma Newswire

Top 10 Highlights from the APAC PE, VC and Startup Ecosystem this Week – 19 Jan 2025

By January 19, 2025 No Comments

Top ten highlights from the APAC PE, VC, and startup ecosystem this week:

  1. eFishery Co-Founders Suspended: Gibran Huzaifah and Chrisna Aditya, co-founders of eFishery, have been suspended by the board following an investigation into alleged financial irregularities.
  2. Alleged Fraud Dating Back to 2018: A forensic audit revealed a complex scheme of financial manipulation dating back to 2018 during the aquatech startup’s Series A round.
  3. Industry Shockwaves: The eFishery saga has reverberated throughout Indonesia’s startup and investor community.
  4. Northstar Group’s Response: Patrick Walujo of Northstar Group highlighted the impact of eFishery’s actions and emphasized the need for a serious investigation.
  5. Indonesia’s Potential: During the Indonesia PE-VC Summit, experts emphasized the country’s attractiveness for investors given its market size and consumer base.
  6. Top Takeaways from the Summit: Insights from the summit included discussions on private equity and venture capital strategies in Indonesia for 2025 and beyond.
  7. Key Fund Closures: Private equity firms like Ardian, responsAbility Investments, and Avendus Capital closed significant funds in Asia-Pacific.
  8. Startup Funding Data: A look at the monthly startup funding data from Greater China and SE Asian markets, highlighting the rebound in dealmaking activity.
  9. M&A Deals in China: Despite challenges, China secured notable M&A deals in 2024, showcasing resilience in its markets.
  10. Notable Deal News: Updates on funding rounds for companies like Sygnum, Saarathi Finance, Aragen, and acquisitions by Gaw Capital Partners and Aditya Birla Fashion and Retail.

APAC Private Markets Research

Explore latest Insights on APAC Private Markets on Smartkarma


Disclaimer:This article by is general in nature and based on publicly available information and not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material. While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars

Also, check out the latest in ECM Research on Smartkarma